TR200100643T2 - Yüksek-çekimli antikorlar - Google Patents

Yüksek-çekimli antikorlar

Info

Publication number
TR200100643T2
TR200100643T2 TR2001/00643T TR200100643T TR200100643T2 TR 200100643 T2 TR200100643 T2 TR 200100643T2 TR 2001/00643 T TR2001/00643 T TR 2001/00643T TR 200100643 T TR200100643 T TR 200100643T TR 200100643 T2 TR200100643 T2 TR 200100643T2
Authority
TR
Turkey
Prior art keywords
samples
hour
antibody
draft
incubating
Prior art date
Application number
TR2001/00643T
Other languages
English (en)
Turkish (tr)
Inventor
John Harrison Peter
Original Assignee
Ks Biomedix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ks Biomedix Ltd filed Critical Ks Biomedix Ltd
Publication of TR200100643T2 publication Critical patent/TR200100643T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007Carcino-embryonic Antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6815Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TR2001/00643T 1998-08-28 1999-08-20 Yüksek-çekimli antikorlar TR200100643T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9818915.2A GB9818915D0 (en) 1998-08-28 1998-08-28 Antibodies

Publications (1)

Publication Number Publication Date
TR200100643T2 true TR200100643T2 (tr) 2001-07-23

Family

ID=10838074

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00643T TR200100643T2 (tr) 1998-08-28 1999-08-20 Yüksek-çekimli antikorlar

Country Status (21)

Country Link
EP (1) EP1107990A1 (es)
JP (1) JP2002525082A (es)
KR (1) KR20010089174A (es)
CN (1) CN1315966A (es)
AU (1) AU5435099A (es)
BG (1) BG105294A (es)
BR (1) BR9913303A (es)
CA (1) CA2340865A1 (es)
EA (1) EA200100287A1 (es)
GB (1) GB9818915D0 (es)
HR (1) HRP20010149A2 (es)
HU (1) HUP0103233A3 (es)
ID (1) ID28905A (es)
IL (1) IL141523A0 (es)
MX (1) MXPA01002248A (es)
NO (1) NO20011006L (es)
PL (1) PL346472A1 (es)
TR (1) TR200100643T2 (es)
WO (1) WO2000012556A1 (es)
YU (1) YU15401A (es)
ZA (1) ZA200101573B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0031284D0 (en) * 2000-12-21 2001-01-31 Ks Biomedix Ltd High affinity antibodies
GB0112844D0 (en) * 2001-05-25 2001-07-18 Psimei Pharmaceuticals Plc Neutron capture therapy
US20030232401A1 (en) * 2002-06-12 2003-12-18 Pugia Michael J. Bacterial test method by glycated label binding
CA2488836A1 (en) * 2002-06-12 2003-12-24 Genencor International, Inc. Methods and compositions for milieu-dependent binding of a targeted agent to a target
JP4982183B2 (ja) * 2003-12-12 2012-07-25 ジェネンコー・インターナショナル・インク Cab分子
CN111848790B (zh) * 2020-08-07 2022-02-22 上海交通大学 一种牛源抗金黄色葡萄球菌的单链抗体及其制备和应用
CN112724255A (zh) * 2021-01-28 2021-04-30 成都金昆生物科技有限公司 靶向癌胚抗原的小分子抗体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081235A (en) * 1989-07-26 1992-01-14 City Of Hope Chimeric anti-cea antibody
GB9014932D0 (en) * 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method

Also Published As

Publication number Publication date
BR9913303A (pt) 2001-10-09
EA200100287A1 (ru) 2001-08-27
YU15401A (sh) 2003-07-07
HUP0103233A2 (hu) 2001-12-28
AU5435099A (en) 2000-03-21
GB9818915D0 (en) 1998-10-21
KR20010089174A (ko) 2001-09-29
MXPA01002248A (es) 2002-05-08
NO20011006D0 (no) 2001-02-27
EP1107990A1 (en) 2001-06-20
WO2000012556A1 (en) 2000-03-09
PL346472A1 (en) 2002-02-11
NO20011006L (no) 2001-02-27
CN1315966A (zh) 2001-10-03
CA2340865A1 (en) 2000-03-09
IL141523A0 (en) 2002-03-10
ID28905A (id) 2001-07-12
JP2002525082A (ja) 2002-08-13
BG105294A (bg) 2001-12-29
ZA200101573B (en) 2002-02-26
HUP0103233A3 (en) 2003-10-28
HRP20010149A2 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
Yolken Enzyme-linked immunosorbent assay (ELISA): a practical tool for rapid diagnosis of viruses and other infectious agents.
WO2002039114A3 (en) Improved assay and reagents or immunological determination of analyte concentration
Heyman et al. An enzyme-linked immunosorbent assay for measuring anti-sheep erythrocyte antibodies
Rennard et al. Enzyme linked immunoassay (ELISA) for connective tissue proteins: type I collagen
FR2662804B1 (fr) Anticorps polyclonaux anti-lh et leurs applications a la detection et/ou au dosage de la lh, chez de multiples especes animales.
WO1986003839A1 (en) Solid phase diffusion assay
Persson et al. Enzyme-linked immunosorbent assay for subclass distribution of human IgG and IgA antigen-specific antibodies
TR200100643T2 (tr) Yüksek-çekimli antikorlar
Shamsuddin et al. Improved enzyme immunoassays using biotin-avidin-enzyme complex
ATE320604T1 (de) Homogene nachweisverfahren zur bestimmung von subpopulationen eines analyten
Linpisarn et al. Sensitive sandwich enzyme immunoassay for serum ferritin on microtitre plates
KR960014336A (ko) 사람 글리센틴에 대한 모노클로날 항체, 이러한 항체를 생성하기 위한 하이브리도마 및 상기 항체를 사용한 사람 글리센틴의 검정방법
Derer et al. Application of the dot immunobinding assay to allergy diagnosis
DE60235011D1 (de) Assays für den präimplantationsfaktor und präimplantationsfaktorpeptide
Tew et al. A radioimmunoassay for human antibody specific for microbial antigens
ES2131279T3 (es) Inmunoensayo de tipo sandwich para n-peptido.
EP0166583A3 (en) Compositions for enzyme immunoassay of prostaglandins
CN204514933U (zh) β2-微球蛋白免疫层析定量检测试纸条
ATE180894T1 (de) Verwendung von polyklonalen humanen anti-htg- autoantikörpern als reagenz für die klinische diagnostik von schilddrüsen-autoimmunerkrankungen sowie reagenziensatz für eine bestimmung von anti-htg-autoantikörpern in patientenseren
ES2076221T3 (es) Derivados geminales de difenilo y su uso en inmunoensayos.
CA2451378A1 (en) Assay for measuring factor viia-antithrombin complexes
DE60027176D1 (de) Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
ES2153066T3 (es) Antigeno para inmunoensayo enzimatico y metodo para medir anticuerpos de eritrocito.
Vertosick Jr et al. Antibodies to native and denatured DNA: Quantitation using an immuno-slot-blot technique